• Je něco špatně v tomto záznamu ?

Flow limitation and dyspnoea in healthy supine subjects during methacholine challenge

J Sulc, CA Volta, Y Ploysongsang, L Eltayara, R Olivenstein, J Milic-Emili

. 1999 ; 14 (6) : 1326-1331.

Jazyk angličtina Země Dánsko

Typ dokumentu klinické zkoušky, srovnávací studie, klinické zkoušky kontrolované, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14058434

Grantová podpora
IZ3935 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Část
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 1994 do Před 18 měsíci
Open Access Digital Library od 1988-01-01

The purpose of this study was to assess whether during standard methacholine (Mch) challenge (concentration up to 128 mg x mL(-1)) healthy supine subjects a) develop tidal expiratory flow limitation (FL) and hyperinflation, and b) whether the onset of tidal FL is associated with dyspnoea. Eight healthy subjects were studied. Dyspnoea was assessed using the Borg scale, FL by the negative expiratory pressure (NEP) method and hyperinflation in terms of decrease in inspiratory capacity (IC). Seven patients became flow limited at Mch doses ranging 4-64 mg x mL(-1), with FL encompassing 34-84% of the control tidal volume. In six of them the onset of tidal FL was associated with little or no dyspnoea and a modest degree of hyperinflation (deltaIC <-0.4 L). In one subject, however, onset of FL was associated with a substantial reduction in IC (0.58 L) and moderately severe dyspnoea. In all of these seven subjects FL was transiently reversed after an IC manoeuvre. In conclusion, the results show that a) most healthy subjects may develop flow limitation and hyperinflation during methacholine challenge in supine position, and b) at onset of flow limitation there is little or no dyspnoea, suggesting that onset of dynamic airway compression per se does not elicit significant dyspnoea. Significant dyspnoea probably only occurs with marked dynamic hyperinflation.

000      
00000naa a2200000 a 4500
001      
bmc14058434
003      
CZ-PrNML
005      
20140523093640.0
007      
ta
008      
140516s1999 dk a f 000 0|eng||
009      
AR
035    __
$a (PubMed)10624762
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Šulc, Jan $7 xx0061770 $u Meakins-Christie Laboratories and Montreal Chest Institute Research Centre, McGill University, Quebec, Canada.
245    10
$a Flow limitation and dyspnoea in healthy supine subjects during methacholine challenge / $c J Sulc, CA Volta, Y Ploysongsang, L Eltayara, R Olivenstein, J Milic-Emili
520    9_
$a The purpose of this study was to assess whether during standard methacholine (Mch) challenge (concentration up to 128 mg x mL(-1)) healthy supine subjects a) develop tidal expiratory flow limitation (FL) and hyperinflation, and b) whether the onset of tidal FL is associated with dyspnoea. Eight healthy subjects were studied. Dyspnoea was assessed using the Borg scale, FL by the negative expiratory pressure (NEP) method and hyperinflation in terms of decrease in inspiratory capacity (IC). Seven patients became flow limited at Mch doses ranging 4-64 mg x mL(-1), with FL encompassing 34-84% of the control tidal volume. In six of them the onset of tidal FL was associated with little or no dyspnoea and a modest degree of hyperinflation (deltaIC <-0.4 L). In one subject, however, onset of FL was associated with a substantial reduction in IC (0.58 L) and moderately severe dyspnoea. In all of these seven subjects FL was transiently reversed after an IC manoeuvre. In conclusion, the results show that a) most healthy subjects may develop flow limitation and hyperinflation during methacholine challenge in supine position, and b) at onset of flow limitation there is little or no dyspnoea, suggesting that onset of dynamic airway compression per se does not elicit significant dyspnoea. Significant dyspnoea probably only occurs with marked dynamic hyperinflation.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a rezistence dýchacích cest $x fyziologie $x účinky léků $7 D000403
650    02
$a bronchoprovokační testy $7 D001985
650    12
$a bronchokonstrikční látky $x diagnostické užití $7 D016085
650    12
$a dyspnoe $x diagnóza $x patofyziologie $7 D004417
650    02
$a usilovný výdechový objem $7 D005541
650    02
$a lidé $7 D006801
650    02
$a měření objemu plic $7 D008176
650    02
$a mužské pohlaví $7 D008297
650    12
$a methacholinchlorid $x diagnostické užití $7 D016210
650    02
$a vrcholová exspirační průtoková rychlost $7 D010366
650    02
$a referenční hodnoty $7 D012016
650    02
$a regresní analýza $7 D012044
650    02
$a senzitivita a specificita $7 D012680
650    02
$a spirometrie $7 D013147
650    02
$a neparametrická statistika $7 D018709
650    02
$a supinační poloha $7 D016683
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
655    _2
$a klinické zkoušky kontrolované $7 D018848
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Volta, C.A.
700    1_
$a Ploysongsang, Y.
700    1_
$a Eltayara, L.
700    1_
$a Olivenstein, R.
700    1_
$a Milic-Emili, J.
773    0_
$t The European respiratory journal $x 0903-1936 $g Roč. 14, č. 6 (1999), s. 1326-1331 $p Eur Respir J $w MED00001660
910    __
$a ABA008 $b B 1607 $y 4 $z 0
990    __
$a 20140516160602 $b ABA008
991    __
$a 20140523093826 $b ABA008
999    __
$a ok $b bmc $g 1025568 $s 857053
BAS    __
$a 3
BMC    __
$a 1999 $b 14 $c 6 $d 1326-1331 $x MED00001660 $i 0903-1936 $m The European respiratory journal $n Eur Respir J
GRA    __
$a IZ3935 $p MZ0
LZP    __
$a NLK 2014-05/lpbo

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...